Table 5.
General and skin cancer specific anxiety within one week of trial consultation and three month follow-up. Values are mean (SD) responses
| Variables | Within 1 week of trial consultation | 3 month follow-up | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Control group | Intervention group | Difference (95% CI) | P value | Control group | Intervention group | Difference (95% CI) | P value | ||
| Speilberger state trait anxiety inventory*: | |||||||||
| All | 34.91 (0.56) n=459 | 33.77 (0.50) n=472 | −1.14 (−2.62 to 0.34) | 0.13 | 34.59 (0.51) n=452 | 33.96 (0.52) n=450 | −0.63 (−2.07 to 0.83) | 0.39 | |
| Referred | 35.45 (1.15) n=118 | 36.18 (0.93) n=158 | 0.73 (−2.16 to 3.62) | 0.62 | 33.61 (0.98) n=118 | 33.85 (0.92) n=154 | 0.24 (−2.43 to 2.90) | 0.86 | |
| Non-referred | 34.72 (0.64) n=341 | 32.56 (0.58) n=314 | −2.16 (−3.87 to 0.46) | 0.013 | 34.94 (0.60) n=334 | 34.02 (0.63) n=296 | −0.92 (−2.64 to 0·80) | 0.29 | |
| Referred minus non-referred | 0.73 (1.28) | 3.62 (1.05) | 2.89 (−0.34 to 6.13) | 0.08 | −1.32 (1.17) | −0.17 (1.10) | 1.16 (−1.99 to 4.31) | 0.47 | |
| Skin cancer worry scale†: | |||||||||
| All | 10.06 (0.13) n=471 | 10.25 (0.15) n=478 | 0.19 (−0.20 to 0.58) | 0.34 | 9.45 (0.14) n=449 | 9.34 (0.14) n=458 | −0.12 (−0.51 to 0.27) | 0.56 | |
| Referred | 9.90 (0.25) n=119 | 10.30 (0.27) n=161 | 0.41 (−0.35 to 1.16) | 0.29 | 9.68 (0.34) n=115 | 9.53 (0.27) n=156 | −0.16 (−1.01 to 0·68) | 0.71 | |
| Non-referred | 10.12 (0.16) n=352 | 10.22 (0.17) n=317 | 0.11 (−0.35 to 0.56) | 0.56 | 9.37 (0.15) n=334 | 9.24 (0.16) n=302 | −0.13 (−0.56 to 0.30) | 0.55 | |
| Referred minus non-referred | −0.22 (0.30) | 0.08 (0.31) | 0.30 (−0.56 to 1.15) | 0.50 | 0.31 (0.33) | 0.28 (0.29) | −0.03 (−0.89 to 0.83) | 0.95 | |
*Six item response (1-4 Likert type responses); short form scaled up to 20 item range of 20-80.
†Six items; score 6-24.